Sponsored Links
| CrystalGenomics Initiates CG100649 Phase 2b Study In Patients With Osteoarthritis |
 |
 |
 |
| Medical News - Arthritis and Rheumatology | |||
|
CrystalGenomics, Inc. (Seoul, Korea) and CG Pharmaceuticals, Inc. (Emeryville, California), a biopharmaceutical company with 3 clinical stage candidates, has announced that the first patient has been enrolled for a Phase 2b clinical study of CG100649, CrystalGenomics' clinical stage novel NSAID candidate, in patients with knee or hip osteoarthritis (OA)... Read more: Arthritis / Rheumatology News From Medical News Today
|